Alpha 2.0
Login Register
» Authors » Mohammad Alidoosti

Mohammad Alidoosti

Explore the profile of Mohammad Alidoosti including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 82
Citations 329
Followers 0
Related Specialties
Cardiology & Vascular Diseases
General Medicine
Endocrinology
Top 10 Co-Authors
Mojtaba Salarifar
Seyed Ebrahim Kassaian
Ebrahim Nematipour
Alireza Amirzadegan
Hamidreza Poorhosseini
Hassan Aghajani
Arash Jalali
Younes Nozari
Alimohammad Hajizeinali
Yaser Jenab
Published In
J Tehran Heart Cent
Arch Iran Med
Crit Pathw Cardiol
Tex Heart Inst J
Kardiol Pol
Affiliations
Soon will be listed here.
Recent Articles
1.
In-hospital and 1-year outcomes of patients without modifiable risk factors presenting with acute coronary syndrome undergoing PCI: a Sex-stratified analysis
Sheikhy A, Fallahzadeh A, Jameie M, Aein A, Masoudkabir F, Maghsoudi M, et al.
Front Cardiovasc Med . 2024 Jan; 10:1235667. PMID: 38173819
Aim: A considerable proportion of patients admitted with acute coronary syndrome (ACS) have no standard modifiable cardiovascular risk factors (SMuRFs: hypertension, diabetes mellitus, dyslipidemia, and cigarette smoking). The outcomes of...
2.
The carrier mobility and superconducting properties of monolayer oxygen-terminated functionalized MXene TiCO
Shayanfar R, Alidoosti M, Nasr Esfahani D, Pourfath M
Nanoscale . 2023 Nov; 15(46):18806-18817. PMID: 37961829
In this study, the carrier mobility of monolayer TiCO was evaluated by employing the Boltzmann transport equation and superconducting transition temperature () of TiCO was determined by utilizing the Migdal...
3.
Colorimetric detection of fluoride and mercury (II) ions using isatin Schiff base skeleton bearing pyridine-2-carboxamidine moiety: Experimental and theoretical studies
Eshghi P, Moafi L, Alidoosti M, Nasr Esfahani D
Spectrochim Acta A Mol Biomol Spectrosc . 2023 Oct; 305:123467. PMID: 37826999
An isatin-Schiff base ligand (ISS) bearing a pyridine-2-carboxamidine moiety was synthesized through a facile and convenient method for the highly selective colorimetric detection of Hg and F ions. The sensing...
4.
Comparison of machine-learning models for the prediction of 1-year adverse outcomes of patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction
Tofighi S, Poorhosseini H, Jenab Y, Alidoosti M, Sadeghian M, Mehrani M, et al.
Clin Cardiol . 2023 Sep; 47(1):e24157. PMID: 37721426
Background: Acute ST-elevation myocardial infarction (STEMI) is a leading cause of mortality and morbidity worldwide, and primary percutaneous coronary intervention (PCI) is the preferred treatment option. Hypothesis: Machine learning (ML)...
5.
The relationship of circulating neuregulin 4 and irisin, and traditional and novel cardiometabolic risk factors with the risk and severity of coronary artery disease
Alipoor E, Hosseinzadeh-Attar M, Vasheghani-Farahani A, Salmani M, Rezaei M, Namkhah Z, et al.
Cytokine . 2023 Aug; 170:156314. PMID: 37591135
Background And Aims: Neuregulin 4 (NRG4) and irisin are adipokines that have been suggested to be associated with cardiometabolic risk factors and coronary artery disease (CAD), but the data are...
6.
Outcome of Percutaneous Coronary Intervention in Old Patients Presenting with Acute Coronary Syndrome
Fallahzadeh A, Sheikhy A, Aein A, Salarifar M, Pourhosseini H, Aghajani H, et al.
Arch Iran Med . 2023 Aug; 25(8):523-532. PMID: 37543874
Background: Octogenarians (age≥80 years) with coronary artery disease constitute a high-risk group and the elderly undergoing percutaneous coronary intervention (PCI) are at higher risk of adverse outcomes compared to young...
7.
Comparative outcomes of percutaneous transvenous mitral commissurotomy between low and high Wilkins score
Alidoosti M, Sattartabar B, Pourhoseini H, Salarifar M, Nematipour E, Hajizeinali A, et al.
Asian Cardiovasc Thorac Ann . 2023 Jul; 31(6):491-497. PMID: 37424238
Background: Percutaneous transvenous mitral commissurotomy (PTMC) is one of the non-surgical methods for patients with significant mitral stenosis. It is less invasive, less complicating with better outcomes compared to surgery....
8.
Impact of Dietary Advanced Glycation End-Product Restriction on Insulin Resistance and Anthropometric Indices in Coronary Artery Patients Treated with Percutaneous Coronary Intervention: A Randomized Controlled Trial
Honarkar-Shafie E, Hosseinzadeh-Attar M, Taheri F, Moosavi N, Yaseri M, Alidoosti M, et al.
J Tehran Heart Cent . 2023 May; 18(1):1-9. PMID: 37252224
Background: Insulin resistance (IR), even in its subclinical state, is a significant risk factor for the onset and progression of coronary artery disease (CAD). IR is a multifactorial condition, and...
9.
Impact of Baseline Estimated Glomerular Filtration Rate Using CKD-EPI Equation on Long-term Prognosis of STEMI Patients: A Matter of Small Increments!
Sadre-Bafghi S, Mohebi M, Hadi F, Parsaiyan H, Memarjafari M, Tayeb R, et al.
Crit Pathw Cardiol . 2022 Aug; 21(3):153-159. PMID: 35994724
Background: Baseline biomarkers including glomerular filtration rate (GFR) guide the management of patients with ST-segment elevation myocardial infarction (STEMI). GFR is a tool for prediction of adverse outcomes in these...
10.
Comparison of Angiographic and Clinical Outcomes After Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction Between Patients With and Without Concomitant COVID-19 Infection
Mohsenizadeh S, Alidoosti M, Jalali A, Tofighi S, Salarifar M, Poorhosseini H, et al.
Crit Pathw Cardiol . 2022 Aug; 21(3):141-146. PMID: 35994723
Objective: COVID-19 infection can involve the cardiovascular system and worsen the prognosis of the patients. This study aimed to investigate the adverse effects of COVID-19 on angiographic and clinical outcomes...